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Aims Congenital coronary artery anomalies produce serious events that include syncope, arrhythmias, myocardial infarction,
or sudden death. Studying the mechanism of coronary development will contribute to the understanding of the disease
and help design new diagnostic or therapeutic strategies. Here, we characterized a new calcineurin–NFAT signalling
which specifically functions in the epicardium to regulate the development of smooth muscle wall of the coronary
arteries.
Methods
and results
Using tissue-specific gene deletion, we found that calcineurin–NFAT signals in the embryonic epicardium to direct cor-
onary smooth muscle cell development. The smooth muscle wall of coronary arteries fails to mature in mice with epi-
cardial deletion of calcineurin B1 (Cnb1), and accordingly these mutant mice develop cardiac dysfunction with reduced
exercise capacity. Inhibition of calcineurin at various developmental windows shows that calcineurin–NFAT signals
within a narrow time window at embryonic Day 12.5–13.5 to regulate coronary smooth muscle cell development.
Within the epicardium, NFAT transcriptionally activates the expression of Smad2, whose gene product is critical for
transducing transforming growth factor b (TGFb)–Alk5 signalling to control coronary development.
Conclusion Our findings demonstrate new spatiotemporal and molecular actions of calcineurin–NFAT that dictate coronary arterial
wall development and a new mechanism by which calcineurin–NFAT integrates with TGFb signalling during embryonic
development.
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1. Introduction
Embryonic development requires intense signalling within and between
tissues to organize the formation of organs, including the coronaryarter-
ies. Formation of the coronary vasculature is essential to support cardiac
growth and function.1,2 Anomalies of coronary arteries can cause
cardiac ischaemia, particularly during exercise, which can then precipi-
tate infarction, arrhythmias, syncope, or sudden cardiac death.3 Con-
genital coronary artery anomalies are found in 0.64–5.6% of patients
undergoing coronary angiography,4 and 20% of coronary anomalies
produce life-threatening events.3 This creates a serious medical
burden to our society, given that coronary artery anomalies are the
second most common cause of sudden cardiac death in young athletes.5
Therefore, studying how cells signal to direct coronary development is
crucial to further our understanding of congenital coronary anomalies
and the pathobiology of coronary arteries.
Coronary arteries are composed of three tissue layers: endothelium,
smoothmuscle cell (SMC) layer, and the adventitial layer.2 Development
of coronary arteries is a complex developmental process: the endothe-
lium is the first layer formed, and the endothelial plexuses then remodel
and recruit SMCs and fibroblasts to form the smooth muscle wall and
adventitia of mature coronary arteries.6 SMCs of coronary arteries
have a fundamental role in cardiac function. These cells maintain coron-
ary vascular tone to regulate cardiac perfusion. During exercise,
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coronary smooth muscle relaxes to dilate the arteries, thereby increas-
ing the blood supply to the heart muscle and enabling the heart to pump
more vigorously to meet the circulatory demand. Abnormalities of
SMCs are crucial in many pathological processes, which include hyper-
tension, atherosclerosis, and vascular restenosis after coronary artery
grafting or stenting surgery.7 Coronary SMCs originate developmentally
from the embryonic epicardium. During development, the epicardial
cells undergo epithelial-to-mesenchymal transformation (EMT) and
through this process give rise to mesenchymal cells that migrate into
the myocardium. Within the myocardium, the epicardially derived mes-
enchymal cells associate with coronary endothelial cells and then differ-
entiate into smooth muscle and adventitial cells of coronary arteries.
Such complex developmental process requires signalling regulation
from the endothelium, myocardium, and epicardium.6,8
Many signalling pathways, including the transforming growth factor
(TGFb1-3), bone morphemic protein (BMP), fibroblast growth factor,
sonic hedgehog (Shh), and Wnt/b-catenin, are essential for the develop-
ment of coronary vasculature.9 –15 These pathways are involved in cell
growth, migration, or differentiation during embryonic heart develop-
ment. For example, the TGFb family of signalling molecules plays an im-
portant role in coronary development controlled by the epicardial
progenitor cells. Mice lacking epicardial Tgfbr3 (TGFb receptor III) or
Alk5 (a type I TGFb receptor) show defects in the migration of epicar-
dially derived mesenchymal cells or abnormalities in coronary SMC dif-
ferentiation.9,16 Although the signalling events may occur in different
cardiac tissues during coronary development, the temporal actions
and interactions among these signalling pathways remain largely
unknown.
Here, we show a new epicardial pathway calcineurin–NFAT that
cooperates with TGFb-Alk5 signalling within the epicardium to regulate
coronary development. Calcineurin is a phosphatase that is activated by
signals fromcell surface receptors or ion channels.17 Once activated, cal-
cineurin dephosphorylates the NFAT transcription factors, triggering
NFAT proteins to translocate into the nucleus to control target gene
expression. Our studies show that calcineurin–NFAT signals within a
distinct developmental window to organize coronary arterial wall devel-
opment. Within the epicardium, calcineurin–NFAT activates the
expression of Smad2 to control the transduction of TGFb-Alk5 signal-
ling essential for coronary artery development.
2. Methods
More detailed methods were described in Supplementary material online.
2.1 Mice
All mouse strains were maintained in outbred backgrounds. The Cnb1f/f,18
Nfatc1f/f,19 Sm22aCre,20 and Gata5Cre21 strains are previously described.
The date of observing a vaginal plug was set as E0.5, and embryonic develop-
ment was confirmed by ultrasonography before sacrificing pregnant mice.22
All animal studies were approved by Stanford University School of Medicine.
Figure 1 Gross phenotype of epicardium-restricted Cnb1 mutant mice. (A and B) Immunostaining of Cnb1 in E11.5 hearts of littermate control (A) and
Gata5Cre;Cnb1f/f (B) mice. White arrow indicates the epicardial (Epi) and endocardial (Endo) border. Red: Cnb1. Blue: DAPI nuclear staining. Scale bar:
100 mm. (C) Body weight distribution of littermate control and Gata5Cre;Cnb1f/f mice. Data represented are means+ SEM. P-value: Student’s t-test.
Error bar: SEM, standard error of the mean. Line represents the mean of body weight. (D) Heart ventricle to body-weight ratio of 2-month-old littermate
control was comparable with that of the Gata5Cre;Cnb1f/f mice. Data shown are means+ SEM. P-value: Student’s t-test. Error bar: SEM, standard error of
the mean. (E) Running time on the treadmill of littermates at 2 month of age. Data represented are means+ SEM. P-value: Student’s t-test. Error bar: SEM,
standard error of the mean.
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2.2 Exercise tolerance test
Maximum exercise capacity was measured by using a rodent treadmill
equipped with an electrical stimulus (Columbus Instruments, Columbus,
OH, USA). Animals were familiarized with running on the treadmill before
exercise testing. The exercise protocol consisted of progressive increase
of the belt speed from 7.5 to 20 m/min by 2.5 m/min and incline from 4 to
208 by 28 at 3 min intervals. Total exercise time was recorded as the
elapsed time to exhaustion. Exhaustion, determined by an observer
blinded to control and mutant group, was defined as the point at which
the animals could not keep pace with the treadmill and had no response
to the electrical stimulus. Data presented are the average of the two runs
for each mouse.
2.3 Echocardiography
The echocardiographer was blinded to the genotypes of the mice tested.
Transthoracic ultrasonography with a GE Vivid 7 ultrasound platform (GE
Health Care, Milwaukee, WI, USA) and a 13 MHz transducer was used to
measure left ventricular function. The left ventricular function was assessed
Figure2 Epicardial deletionofCnb1 causesheartdysfunction. (A andB)Representativeechocardiographic image of the left ventricle of littermatecontrol
and Gata5Cre;Cnb1f/f mice at 2 month of age. (C) Echocardiographic measurement of fractional shortening of the left ventricle of 2-month-old littermate
control and Gata5Cre;Cnb1f/f mice. Data represented are means+ SEM. P-value: Student’s t-test. Error bar: SEM, standard error of the mean. (D and E)
Echocardiographic measurement of LVIDd and LVIDs of the left ventricle of 2-month-old littermate control and Gata5Cre;Cnb1f/f mice. Data shown are
means+ SEM. P-value: Student’s t-test. Error bar: SEM, standard error of the mean. (F and G) Representative dP/dt tracing of the left ventricle of
2-month-old littermatecontrol andGata5Cre;Cnb1f/fmice.Y-axis: mmHg/s.X-axis: time (s). (H )Maximal dP/dtof the left ventricle of 2-month-old littermate
control and Gata5Cre;Cnb1f/f mice. Data represented are means+ SEM. P-value: Student’s t-test. Error bar: SEM, standard error of the mean. (I ) mRNA
expression of Nppa and Nppb in 2-month-old hearts of littermate control and Gata5Cre;Cnb1f/f mice. Data shown are means+ SEM. P-value: Student’s
t-test. Error bar: SEM, standard error of the mean.
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by the M-mode scanning of the left ventricular chamber, standardized by
two-dimensional, short-axis views of the left ventricle at the mid-papillary
muscle level. P-values were calculated by Student’s t-test. Error bars indicate
standard error of mean.
2.4 Histology, immunostaining, trichrome
staining, and Weigert’s Resorcin-Fuchsin
staining
Histology, immunostaining, trichrome staining, and Weigert’s Resorcin-
Fuchsin (Cat#: 26370, Electron Microscopy Sciences) staining were per-
formed as described.20,23,24 The primary antibodies used for immunostaining
included: rabbit anti-Calcineurin (07-068 Upstate), rabbit anti-Myh11
(BT-562, Biomedical), rabbit anti-Calponin (ab46794, Abcam), mice anti-
alpha smooth muscle actin (a-SMA) (A2547, Sigma), rabbit anti-Mmp9
(ab38898, Abcam), rabbit anti-p-Smad2/3 (sc-11769-R, Santa Cruz Biotech-
nology), anti-b-catenin (ab6302, Abcam), rabbit anti-p-Smad1/5/8 (#9511,
cell signaling), rabbit anti-Smad2 (ab33875, Abcam), and rabbit anti-Smad3
(ab28379, Abcam).
2.5 Cyclosporin treatment
Pregnant females were injected with cyclosporin A (CsA) intraperitoneally
during the time windows indicated in Figure 4J. CsA was administered as
described previously.25 CsA was administered at a dose of 50 mg/kg
through i.p. injection twice a day at 9:00–10:00 a.m. and at 19:00–20:00
p.m. Newborn mice were harvested for staining. Control females were
injected with phosphate-buffered saline at the same time points.
2.6 Reporter assay
The Smad2 promoter (7.5 kb,27028 to+490) was cloned into pREP4-Luc
vector as described previously.24 The construct was then transfected into
293 T cells with lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) along
with pREP7-RL as a transfection efficiency control, constitutive nuclear
Nfatc4 (Nfatc4 SS17,1680AA)26 expression vector with the appropriate
empty vector control. Luciferase activity was measured and normalized to
a cotransfected Renilla luciferase construct using the Dual-Luciferase
Reporter System (Promega, Madison, WI, USA).
2.7 Reverse transcription-quantitative PCR
(RT–qPCR)
RNA extraction wasperformed using TRIzol (Invitrogen) and 150 ng of puri-
fied RNA were used as a template to synthesize cDNA using the Reverse
Transcription Mix (Bio-rad). RT–qPCR reactions were performed using
SYBR green master mix (BioRad, Hercules, CA, USA) with an Eppendorf
realplex, and the primer sets were tested to be quantitative. Primer Thresh-
old cycles and melting curve measurements were performed with software.
The primers used in the assay are described in Supplementary material
online, Table S1. P-values were calculated by Student’s t-test. Error bars
indicate standard error of mean.
2.8 Chromatin
immunoprecipitation-quantitative PCR
The chromatin immunoprecipitation (ChIP) assay was described
previously.23,24 Chromatin was sonicated to generate average fragment
sizes of 200–600 bp, and immunoprecipitated using anti-Nfatc4 antibody
(ab62613, Abcam), and normal rabbit IgG. Isolation and purification of
immunoprecipitated and input DNA were done according to the manufac-
turer’s protocol (Magna ChIP Protein G Magnetic Beads, Cat# 16-662,
Millipore), and RT–qPCR analysis of immunoprecipitated DNA was per-
formed. PCR signals of individual ChIP reaction was standardized to its own
input PCR signals and normalized to IgG ChIP PCR signals. PCR primers
(listed in Supplementary material online, Table S2) were designed to amplify
the conserved promoter regions containing NFAT binding site of rat Smad2.
3. Results
3.1 EpicardialCnb1-null mice exhibit cardiac
dysfunction with reduced exercise capacity
We used Gata5Cre21 and loxP-flanked alleles of Cnb118 to disrupt calci-
neurin (Cnb1) in the developing epicardium. Immunostaining showed
that Cnb1 was present in the developing heart, including the endocar-
dium, myocardium, and epicardium (Figure 1A). In Gata5Cre;Cnb1f/f,
Figure 3 Epicardial deletion of Cnb1 induces heart ECM deposition
and fibrosis. (A–D) Trichrome staining (A and B, red: cardiomyocytes.
Blue: fibrosis) and Sirus red staining (C and D, red: Collagen) of fibrosis
in 2-month-old littermate control and Gata5Cre;Cnb1f/f hearts. Scale
bar: 100 mm. (E and F ) Weigert’s Resorcin Fuchsin staining of elastic
fibers in 2-month-old littermate control and Gata5Cre;Cnb1f/f hearts.
Dark blue: elastic tissues. Pink: tissue elements. Scale bar: 100 mm.
(G) The quantitation of the fibrotic area by the measurement of sec-
tions stained as in (A) and (B). Data shown are means+ SEM.
P-value: Student’s t-test. Error bar: SEM, standard error of the mean.
(H ) Expression of Col1a1, Col1a3, Timp1, Mmp9, Osf2 in E15.5 hearts
of littermate control and Gata5Cre;Cnb1f/f mice. Data represented
are means+ SEM. P-value: Student’s t-test. Error bar: SEM, standard
error of the mean. (I and J ) Immunostaining of Mmp9 in E15.5 heart
of littermate control and mutant mice. Green: Mmp9. Blue: DAPI
nuclear staining. *Epicardial border. Scale bar: 100 mm.
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Cnb1 was absent in the epicardium but present in the myocardium and
endocardium (Figure 1B), and quantitation showed an 99.3% efficiencyof
Cnb1 disruption in the epicardium at E11.5 (data not shown). Although
previous studies suggested that Gata5Cre may direct gene deletion in
the myocardium,21 we did not observe any ectopic deletion of Cnb1 in
the myocardium by Gata5Cre in our inbred strains of mice; neither
was there Gata5Cre activity detected in the myocardium (Supplemen-
tary material online, Figure S1). The Gata5Cre;Cnb1f/f mice were born
at expected Mendelian ratios, and on average the mutant mice had
reduced body weight at 2 months of age, some of the mutant mice
were easily identified because of their smaller body size (Figure 1C).
The heart ventricle/body-weight ratio of all Gata5Cre;Cnb1f/f mice,
however, was comparable with that of control littermates (Figure 1D).
Histological analysis showed that the thickness of trabeculae and myo-
cardial wall was normal in the Gata5Cre;Cnb1f/f hearts at E16.5, P1, and
2 months of age (Supplementary material online, Figure S2A–J). No
apoptotic cells were detected in either control or mutant hearts by
TUNEL staining (Supplementary material online, Figure 3A–C). Tread-
mill exercise analysis27 showed that the Gata5Cre;Cnb1f/f mice had
severely reduced exercise capacity by the age of 2 months (Figure 1E),
suggesting cardiac dysfunction. Echocardiography showed that Gata5-
Cre;Cnb1f/f mice had 33% reduction of left ventricular fractional
shortening, accompanied by 25% increase in end-systolic left ventricular
diameter (LVIDs) with preservation of end-diastolic left ventricular
diameter (LVIDd) (Figure 2A–E). Cardiac catheterization of the left ven-
tricleGata5Cre;Cnb1f/f mice showed that the maximal rates of generating
systolic pressure (+dP/dt) and of diastolic relaxation (2dP/dt) were
reduced by 23 and 21%, respectively (Figure 2F–H). RT–qPCR of
cardiac stress markers—Nppa (ANF) and Nppb (BNP)—showed that
both Nppa and Nppb mRNA were highly elevated in the adult Gata5-
Cre;Cnb1f/f hearts (Figure 2I). Collectively, these findings indicate that
mice lacking epicardial Cnb1 develop heart failure in adulthood.
3.2 Epicardial Cnb1-null hearts show
increased elastin and collagen deposition
in coronary arteries
Histological analysis of Gata5Cre;Cnb1f/f hearts showed extensive inter-
stitial fibrosis (Figure 3A, B, and G), as well as intense collagen and elastin
deposition (Figure 3C–F) in the coronary arteries. These results suggest
impaired regulation of extracellular matrix (ECM) in the mutant hearts.
To identify the developmental causes of ECM defects, we examined em-
bryonicday15.5 (E15.5) hearts for theexpressionofECM-relatedgenes.
These genes includedCol1a1,Col3a1, Timp1,Mmp-9, andOsf2.28 Among
Figure4 Epicardial calcineurin regulates coronary smooth muscle development. (A and B) Haematoxylin and eosin sections of P1 heart coronary artery.
Scalebar: 100 mm. (C–H) Immunostaining ofa-SMA, Myh11 andCalponin in P1 hearts of littermatecontrol andGata5Cre;Cnb1f/fmice. Red:a-SMA,Myh11,
or Calponin. Blue: DAPI nuclear staining. Scale bar: 100 mm. (I ) Quantitation of smooth muscle cells per coronary vessel by the measurement of sections
stained as in (C–H). Data shown are means+ SEM. P-value: Student’s t-test. Error bar: SEM, standard error of the mean. (J ) Summary of the CsA treatment
protocol. (K–N) Immunostaining of Myh11 in P1 heart of control and CsA-treated mice. Red: Myh11 immunostaining. Blue: DAPI nuclear staining. Scale bar:
100 mm.
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Figure5 Calcineurin controls TGFb/Smad2 signalling to regulate coronary SMC development. (A) The exercise treadmill test of 2-month-old littermate
control and Gata5Cre;Nfatc1f/f mice. Data shown are means+ SEM. P-value: Student’s t-test. Error bar: SEM, standard error of the mean. (B) Echocardio-
graphic measurement of fractional shortening of the left ventricle of 2-month-old littermate control and Gata5Cre;Nfatc1f/f mice. P-value: Student’s t-test.
Error bar: SEM, standard error of the mean. (C and D) Trichrome staining of fibrosis in 2-month-old littermate control and Gata5Cre;Nfatc1f/f hearts. Red:
cardiomyocytes. Blue: fibrosis. Scale bar: 100 mm. (E and F ) Immunostaining of Myh11 in P1 heart of littermate control andGata5Cre;Nfatc1f/f mice. Brown:
Myh11. Blue: haematoxylin nuclear staining. Scale bar: 100 mm. (G andH ) Immunostaining of Myh11 in P1 heart of littermate control and Sm22aCre;Cnb1f/f
mice. Brown: Myh11. Blue: haematoxylin nuclear staining. Scale bar: 100 mm. (I and J ) Immunostaining ofb-catenin in E12.5 hearts of littermate control and
Gata5Cre;Cnb1f/f mice. Green:b-catenin immunostaining. Blue: DAPI nuclear staining. Scale bar: 100 mm. (K and L) Immunostaining of p-Smad1/5/8 in E12.5
hearts of littermate control and Gata5Cre;Cnb1f/f mice. Brown: p-Smad1/5/8 staining. Blue: haematoxylin nuclear staining. Scale bar: 100 mm. (M and N )
Co-immunostaining ofa-SMA and p-Smad2/3 in P1 hearts of littermate control andGata5Cre;Cnb1f/fmice. Green:a-SMA staining, Red: p-Smad2/3 staining.
Blue: DAPI nuclear staining. Scale bar: 100 mm. Arrow indicates the coronary artery smooth muscle layer. (O–R) Immunostaining of Smad2 and Smad3 in
E12.5 hearts of littermate control andGata5Cre;Cnb1f/f mice. Green: Smad2, Smad3 immunostaining. Scale bar: 100 mm. Blue: DAPI nuclear staining. (S and
T ) Quantitation of Smad2, Smad3 mRNA in control or CsA-treated (500 ng/mL) rat EMC cells. n ¼ 5. Data shown are means+ SEM. P-value: Student’s
t-test. Error bar: SEM, standard error of the mean. (U ) Western blot analysis of Smad2, Smad3 and pSmad2/3 in control or CsA-treated (500 ng/mL) rat
EMC cells.
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these genes, onlyMmp9, a key metalloprotease that degrades elastin and
collagen,29,30 had 62% reduction (P ¼ 0.009) in E15.5 Gata5Cre;Cnb1f/f
hearts; the other genes had no significant changes (Figure 3H). Immunos-
taining confirmed the reduction of Mmp9 in the mutant E15.5 hearts
(Figure 3I and J ). The down-regulation of Mmp9 provides an explanation
for the increased ECM deposition around coronary vessels.
3.3 Epicardial Cnb1 is required for the
differentiation of coronary SMCs
Given that embryonic epicardium gives rise to fibroblasts and coronary
SMCs, deletion of Cnb1 in the epicardium may cause abnormalities of
these two cell populations. We first investigated the function of
cardiac fibroblasts by testing their ability to synthesize and secrete
ECM proteins. Immunostaining of periostin, a component of the ECM
specifically secreted by cardiac fibroblasts,31 showed the normal distri-
bution and abundance of periostin in the mutant hearts relative to that of
littermate controls (Supplementary material online, Figure S4A and B).
Furthermore, Col1a1 and Col1a3, which are the most highly secreted
collagens by cardiac fibroblasts, had normal expression in the mutant
hearts (Figure 3H). These findings suggest normal fibroblast function in
Gata5Cre;Cnb1f/f hearts. To test coronary SMC development, we first
analysed the patterning of coronary arteries by vascular casting.32 The
patterning of right and left coronaryarteries in mutantmicewas compar-
able with that of littermate control mice at 2 months of age (Supplemen-
tary material online, Figure S5A–E). Histology of coronary arteries
showed that the smooth muscle layer had comparable thickness in the
control and mutanthearts (Figure4A–B). We thenexamined SMCdiffer-
entiation by testing their expression of differentiation markers, including
alpha smooth muscle actin (a-SMA), smooth muscle myosin heavy chain
(Myh11), and Calponin (Figure 4C–H). Immunostaining showed that the
expression of those markers was greatly reduced in coronary arteries of
Gata5Cre;Cnb1f/f mice at postnatal Day 1 (P1) (Figure 4C–H; Supplemen-
tary material online, Figure S6A and B). Despite the abnormal differenti-
ation, the number of coronary SMCs that faintly expressed the markers
in the mutant hearts was comparable with the number of well-
differentiated SMCs in the control hearts (Figure 4I). The normal
amount but poor differentiation of mutant coronary SMCs suggests
that there is no defect of epicardially derived mesenchymal cells to
migrate to the arteries but a defect of those cells to differentiate into
mature coronary SMCs in the epicardial Cnb1-null hearts.
3.4 Epicardial calcineurin–NFAT signals at
E12.5–13.5 for coronary smooth muscle
development
To define the developmental window of Cnb1 action for coronary SMC
development, we used CsA to inhibit calcineurin activity in embryos at
different gestational ages.23,25 Pregnant mice were treated with CsA at
various developmental windows (E11.5–12.0, E12.5–13.0, and
E13.5–14.0), and embryos exposed to CsA or control vehicles were
harvested at P1 for coronary SMC immunostaining (Figure 4J). Pups
exposed to CsA at E11.5–12.0 and E13.5–14.0 exhibited normal
Myh11 in coronary SMCs (Figure 4K, L, and N). Conversely, pups with
CsA exposure at E12.5–13.0 showed drastic reduction of Myh11 in cor-
onary SMCs (Figure 4M). These observations indicate a specific temporal
requirement of calcineurin–NFAT signalling beginning at E12.5 for
coronary smooth muscle development.
3.5 Nfatc1 is not essential in the epicardium
for heart or coronary development
Previous work suggested that disruption of Nfatc1 in the epicardium
causes embryonic lethal by E18.5, resulting in the reduction of
COL1A1 protein and cardiac fibrous matrix formation.33 However,
this report is inconsistent with the lackof Nfac1 expression in the epicar-
dium as shown by many other studies.23,25,34,35 To address the contra-
diction, we further tested the role of epicardial Nfatc1 in heart
development and used the Nfatc1f/f mice19 to generate epicardial-
specific Nfatc1 knockout mice (Gata5Cre;Nfatc1f/f). We found that
these mice lived to adulthood and were indistinguishable from their lit-
termate controls. They exercised normally on the treadmill (Figure 5A),
and the Gata5Cre;Nfatc1f/f hearts had normal left ventricular fractional
shortening (Figure 5B), indicating the absence of cardiac dysfunction.
Histological analysis showed normal ECM in the heart and coronary ar-
teries (Figure 5C and D). Myh11 immunostaining showed normal coron-
ary SMC development in P1 Gata5Cre;Nfatc1f/f hearts (Figure 5E and F ).
These observations indicate that Nfatc1 is not essential in the epicar-
dium for heart or coronary development or embryonic survival, which
is in accord with the absence of Nfatc1 expression in the epicar-
dium.23,25,34,35 Given that Nfatc3/c4 are expressed in the epicardium,25
epicardial calcineurin likely signals through Nfatc3/4 to regulate coron-
ary smooth muscle development.
3.6 Calcineurin does not function in smooth
muscle or myocardial cells for coronary
development
To exclude that calcineurin might function in smooth muscle or myocar-
dial cells for coronary smooth muscle development, we used a
Sm22aCre mouse line to delete Cnb1 in smooth muscle and myocardial
cells.20,24,36 We found that Sm22aCre;Cnb1f/f mice lived to adulthood
without defects in coronary SMC differentiation (Figure 5G and H ).
These observations further support a specific role of calcineurin in the
epicardial or epicardially derived mesenchymal cells for coronary wall
development.
3.7 Calcineurin–NFAT activates Smad2 in
the epicardium
EpicardialWnt/b-catenin,TGFb, and BMPsignalling areessential forepi-
cardial progenitor cells to differentiate into coronary SMCs.9 –12 To test
if these signalling events were disrupted in mice lacking epicardial Cnb1,
we examined epicardial Wnt/b-catenin, TGFb, and BMP signalling by
testing its downstream effectors—b-catenin, activated Smad2/3
(p-Smad2/3), and activated Smad1/5/8 (p-Smad1/5/8). By immunostain-
ing, we observed no difference of b-catenin and p-Smad1/5/8 between
Gata5Cre;Cnb1f/f and control littermates at E12.5 (Figure 5I–L). Con-
versely, p-Smad2/3 was nearly absent in the nuclei of coronary SMCs
of Gata5Cre;Cnb1f/f mice (Figure 5M and N ), indicating severely compro-
mised TGFb–Smad2/3 signalling in the absence of calcineurin. We next
tested the expression of Smad2 and Smad3 in the developing epicar-
dium. Smad2 proteins were dramatically diminished in the epicardium
of E12.5 Gata5Cre;Cnb1f/f mice (Figure 5O and P), whereas Smad3 pro-
teins were normal (Figure 5Q and R). Furthermore, in a rat epicardial
cell line,37 inhibition of calcineurin by CsA caused down-regulation of
Smad2 and phosphoSmad2/3 but without changes of Smad3, as shown
by RT–qPCR and/or western blot analysis (Figure 5S–U). Both the
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Figure6 Calcineurin–NFAT directly regulates Smad2expression in epicardial cells. (A) Sequence alignment of the Smad2promoter fromrat, human and
rhesus macaque. Peak heights indicate degree of sequence homology. Black boxes (s1–s5) are regions of high sequence homology containing Nfat binding
site (GGAAA) and were further analysed by ChIP. Red, promoter elements. Green, transposons/simple repeats. (B) Quantitation of Nfatc4 ChIP on the
Smad2 promoter in control or 500 ng/mL CsA-treated rat EMC cells. Data shown are means+ SEM. P-value: Student’s t-test. Error bar: SEM, standard
error of the mean. (C) Luciferase reporter assay of the Smad2 promoter (7.5 kb, 27028 to +490) in 293 T cells. Data shown are means+ SEM.
P-value: Student’s t-test. Error bar: SEM, standard error of the mean. (D) Calcineurin–NFAT signalling functions during distinct time windows to regulate
cardiovascular development. (E) Working model of cross-talk between calcineurin–NFAT and TGFb signalling and molecular signals between epicardial
and myocardial cells during coronary vessel development. EMT, epithelial to mesenchymal transition; TF, transcription factor; CaN, calcineurin;
P, phosphate.
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in vivo and in vitro data, therefore, indicate that calcineurin is essential for
Smad2 expression in the epicardium.
3.8 Epicardial NFAT directly regulates
Smad2 expression for coronary arterial
development
To determine whether Nfat transcriptionally activated Smad2 expres-
sion, we examined the binding of Nfatc4, which is predominantly
expressed in the epicardium,25 to the Smad2 promoter in rat epicar-
dial/mesothelial cells (EMCs).37 With sequence alignment, we identified
five regions (s1–s5), which contains putative NFAT binding sites
(GGAAA), in the5.5 kb of rat Smad2promoter that are evolutionarily
conserved among rhesus macaque, rat, and human (Figure 6A). ChIP
assay using anti-Nfatc4 antibody showed that Nfatc4 was associated
with s1–s5 regions, but not the non-conserved region in EMCs
(Figure 6B). To test if such Nfatc4 binding to Smad2was controlled by cal-
cineurin, we treated EMCs with CsA to inactivate calcineurin and then
performed the ChIP assay. CsA treatment, indeed, abolished Nfatc4’s
binding to these Smad2 promoter sites, indicating that calcineurin
signals Nfatc4 to target Smad2 promoter. To further test the transcrip-
tional activity of Nfatc4 on the Smad2 promoter, we cloned 7.5 kb of
Smad2 upstream promoter (27028 to +490) into episomal luciferase
reporter pREP424 and then transfected the constructs into 293 T
cells. We used 293 T cells as a surrogate for reporter assays because
EMCs were resistant to transfection by various methods attempted.
By measuring the luciferase activity,we found that the expression of con-
stitutively nuclear Nfatc4 caused 2.3-fold increase of the Smad2 pro-
moter activity (Figure 6C). These ChIP studies and reporter assays,
together with the in vivo observations, suggest that calcineurin activates
NFATc in the epicardial cells to transcriptionally activate Smad2.
4. Discussion
Our studies show that anomalous coronary arterial wall development
results in cardiac dysfunction and exercise intolerance in adult. Here,
we demonstrate a previously unknown temporospatial, molecular func-
tion of calcineurin–NFAT signalling in the epicardial progenitor cells to
direct coronary arterial wall formation (Figure 6D). Combined with pre-
vious studies that show how the endothelial calcineurin–NFAT signal
controls coronary endothelial angiogenesis,25 the current studies indi-
cate that NFAT signalling functions in distinct tissues and at different
times to organize the sequence of coronary angiogenesis and arterial
wall development. NFAT signalling first functions in endothelial cells at
E10.5–E11.5 to pattern coronary endothelial tubes, and it then activates
the epicardial/epicardially derived mesenchymal cells at E12.5–E13.5 to
differentiate into SMCs that assemble with the endothelial tubes to form
mature coronary arteries (Figure 6D).
Such sequential NFAT signalling from the endothelium to the epicar-
dium to orchestrate coronary development is reminiscent of the se-
quential NFAT signalling between the endocardium and myocardium
to direct distinct morphogenetic steps of heart valve development.23
Myocardial NFAT signals at E9.5 to initiate EMT of atrioventricular cush-
ions, and endocardial NFAT signals at E11.5 to direct the elongation of
heart valve leaflets (Figure 6D). These four waves of NFAT signalling at
different spatiotemporal domains of the developing heart thus provide
a model in which calcineurin–NFAT determines the sequence of mor-
phogenetic events of cardiovascular tissues.
Calcineurin in the epicardium or epicardium-derived cells controls
the expression of Mmp-9 in the heart. Because Mmp-9 is a key metallo-
protease that degrades elastin and collagen,29,30 the reduction of Mmp-9
in epicardialCnb1-null hearts results in increased elastin and collagen de-
position around the coronary arteries. Such excessive collagen depos-
ition and the lack of maturation of coronary SMCs, in combination,
impair the dilatation of coronary arteries in response to increased myo-
cardial demand. During exercise, coronary arteries would normally
dilate to increase cardiac perfusion to meet the increased metabolic
demand of cardiomyocytes. Such dilation of coronary arteries requires
the relaxation of coronary SMCs. In the mutant heart, the abnormal cor-
onary SMCs with fibrosis may not only impair coronary muscle relax-
ation, but also increase the stiffness of coronary arteries, leading to
failure of coronary artery dilatation and thus exercise-induced cardiac
dysfunction observed in the mutant mice.
Our studies show a previously unknown molecular interaction by
which calcineurin–NFAT controls the expression of Smad2, a critical
intermediate that transduces TGFb signalling. In mice TGF-b1, TGF-b
receptors, and Smad proteins are all essential for embryonic vascular
development. Loss of any of these components leads to defects in
SMC recruitment and/or differentiation during vascular development.38
The TGFb family of signalling molecules also plays an important role in
coronarydevelopment controlledby the epicardial progenitorcells. Epi-
cardial Tgfbr3-null mice display diminished invasion of the epicardially
derived mesenchymal cells into the myocardium, resulting in abnormal
coronary vessel formation.16 In mice lacking epicardial Alk5, a type I
TGFb receptor, the coronary SMCs are reduced in amount and fail to
mature,9 a phenotype also observed the epicardial Cnb1-null hearts
(current studies). The finding that calcineurin–NFAT controls Smad2
expression in the epicardium, coupled with the similar phenotype of
epicardial Alk5-null heart, suggest that calcineurin–NFAT cooperates
with TGFb–Alk5 signalling through Smad2 in the epicardium to regulate
coronary smooth muscle development (Figure 6E).
Besides enabling TGFb–Alk5 to signal through Smad2, the calci-
neurin–NFAT pathway may respond to Shh and vascular endothelial
growth factor (VEGF) to regulate coronary arterial wall development.
Shh released from the epicardium can activate smoothen in the myocar-
dial cells to trigger the expression and release VEGF,13 which is capable
of activating the calcineurin–NFAT pathway.25 VEGF from the myocar-
dium may then activate the endothelial calcineurin–NFAT25 and epicar-
dial calcineurin–NFAT, respectively, to promote coronary endothelial
patterning and smooth muscle wall formation. Further studies will be
needed to elucidate how the calcineurin–NFAT may orchestrate Shh/
smoothen–VEGF and TGFb signalling to organize the interactions
among epicardial, myocardial, and endothelial cells during coronary
artery development.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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